{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T03:19:30Z","timestamp":1780456770287,"version":"3.54.1"},"reference-count":36,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2026,3,4]]},"DOI":"10.1080\/14740338.2024.2446421","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T09:06:11Z","timestamp":1735031171000},"page":"573-580","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Adverse events in patients with castration-resistant prostate cancer treated with ra-223: a retrospective pharmacovigilance study"],"prefix":"10.1080","volume":"25","author":[{"given":"Lei","family":"Yang","sequence":"first","affiliation":[{"name":"The First Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqiang","family":"Zeng","sequence":"additional","affiliation":[{"name":"The First Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuantao","family":"Wang","sequence":"additional","affiliation":[{"name":"The First Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faping","family":"Li","sequence":"additional","affiliation":[{"name":"The First Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,12,25]]},"reference":[{"key":"e_1_3_7_2_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492"},{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-022-01145-x"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2223-4683.2015.05.02"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.1177\/1758834014529176"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2009.05429.x"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.7150\/thno.73152"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2021.07.014"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2303974"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/pcan.2011.7"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1586\/14737140.2015.999045"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S122417"},{"key":"e_1_3_7_13_1","first-page":"3120","article-title":"Significant antitumor effect from bone-seeking, alpha-particle-emitting (223)Ra demonstrated in an experimental skeletal metastases Model","volume":"62","author":"Henriksen G","year":"2002","unstructured":"Henriksen G, Breist\u00f8l K, Bruland \u00d8S, et al. Significant antitumor effect from bone-seeking, alpha-particle-emitting (223)Ra demonstrated in an experimental skeletal metastases Model. Cancer Res. 2002;62:3120\u20133125.","journal-title":"Cancer Res"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1213755"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw065"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1385466"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35221"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-018-01389-4"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2018.03.007"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1001"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.677"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050466"},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1266890"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.2473"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-57909-y"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/iju.13170"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-017-0369-x"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.36.6_suppl.291"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2015.1021332"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-63302-2"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2016.07.027"},{"key":"e_1_3_7_32_1","first-page":"266","article-title":"3-year safety follow-up of radium-223 dichloride (ra-223) in patients (pts) with castration-resistant prostate cancer (CRPC) and symptomatic bone metastases (mets) from ALSYMPCA","volume":"38","author":"Kramer MW","year":"2015","unstructured":"Kramer MW, Kuczyk MA, Parker C, et al. 3-year safety follow-up of radium-223 dichloride (ra-223) in patients (pts) with castration-resistant prostate cancer (CRPC) and symptomatic bone metastases (mets) from ALSYMPCA. Oncol Res Treat. 2015;38:266\u2013266.","journal-title":"Oncol Res Treat"},{"key":"e_1_3_7_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.remn.2019.04.004"},{"key":"e_1_3_7_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2024.101720"},{"key":"e_1_3_7_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.35040"},{"issue":"2","key":"e_1_3_7_36_1","first-page":"536","article-title":"Radium-223 in the treatment of metastatic castrate-resistant prostate cancer","volume":"115","author":"Peters N","year":"2022","unstructured":"Peters N, Bambury RM, Power DG, et al. Radium-223 in the treatment of metastatic castrate-resistant prostate cancer. Ir Med J. 2022;115(2):536.","journal-title":"Ir Med J"},{"key":"e_1_3_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2022.06.057"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2024.2446421","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T15:57:59Z","timestamp":1772726279000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2024.2446421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,25]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,4]]}},"alternative-id":["10.1080\/14740338.2024.2446421"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2024.2446421","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,25]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-06-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}